BusinessHealthMedical DevicesNews

Cardiac Biomarkers Market Trend, Segmentation, Top Key Players Analysis and Forecast Till 2025

Selbyville, Delaware: The Exploration study offers deep assessment of the Global Cardiac Biomarkers Market and helps market participants to gain a solid base in the industry. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, historical data, facts and statistically supported and industry certified market data.

Global cardiac biomarkers market to reach USD 4,957.1 million by 2025. Global cardiac biomarkers market is valued at approximately USD 1,241 million in 2017 and is anticipated to grow with a healthy growth rate of more than 18.9 % over the forecast period 2018-2025. Rising prevalence of cardiovascular diseases cost effective device, non-invasive method, accuracy in prediction, helpful in clinical trials, multi-application, increasing point of care application along with the technological advancements using cardiac biomarkers are some key trends that are responsible for the wide adoption of cardiac biomarkers globally.

Request Sample Copy Of this Report at: https://www.marketstudyreport.com/request-a-sample/2452791/?utm_source=marketwatch.com&utm_medium=TS

Global cardiac biomarker market is majorly driven by rising prevalence of cardiovascular diseases. Cardiovascular diseases such as circulatory diseases, heart attacks and strokes are the leading cause for the premature death across the world. Cardiovascular diseases are caused by rising stress level and work pressure, harmful use of alcohol, unhealthy diet, obesity, tobacco use, and physical inactivity and it is most popular in aging population. Thus, cardiovascular diseases are the major cause of death across the globe.

According the World Health Organization (WHO), in 2015 around 17.7million people died from cardiovascular diseases, signifying 31 % of global deaths, out of these 7.4million died due to coronary heart disease and 6.7 million died due to stroke across the world. As a result, the demand & adoption of cardiac biomarker would increase thereby, aiding the growth of the market over the forecast period of 2018-2025.  Key market challenge for the global cardiac biomarker market is approval clinical validity and utility of biomarkers- based tests. However, to overcome this challenge the market also has various opportunities such as point of care testing using cardiac biomarkers, future developments in novel cardiac biomarkers and demand of personalized medicine.

On the basis of segmentation, the cardiac biomarkers market is segmented into type, application and location of testing. The type segment of global Cardiac Biomarkers market is classified into creatine Kinase (CK-MB), Troponins (T.I), myoglobin, Natriuretic Peptides (BNP & NT-PROBNP), ischemia modified albumin, others. Based on application segment the global cardiac biomarkers market is classified into myocardial infarction, congestive heart failure, acute coronary syndrome, Atherosclerosis, other applications of which myocardial infarction holds the highest share in the global cardiac biomarkers market due to high prevalence of cardiovascular diseases. The location of testing segment includes point of care testing and laboratory testing of which point of care accounts for the fastest growing segment due to clinicians and doctors mainly use point of care cardiac testing for quick testing and monitoring patients who are having chest pain.

The regional analysis of cardiac biomarkers market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America have occupied major share in the global cardiac biomarkers market. The major reasons for the dominance of North America are high CVD prevalence rates, high demand for cardiac testing and rising awareness towards cardiac diagnostics solutions. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific region is witnessed owing to rising affordability for the advanced cardiac treatments, modernization in the countries and increasing disposable income.

The leading market players include-

  • Roche Diagnostics
  • Abbott Laboratories,
  • Siemens Healthcare,
  • Alere Inc.,
  • Becton, Dickinson and Company,
  • Bio-Rad Laboratories,
  • BioMerieux,
  • Randox laboratories,
  • Beckman Coulter
  • Thermo Fisher Scientific

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:   

Myocardial muscle Creatine Kinase (CK-MB)

Myoglobin

Troponins (T and I)

Ischemia Modified Albumin (IMA)

Brain Natriuretic Peptide (BNPs) or NT-proBNP

Others

By Application:   

Congestive Heart Failure

Myocardial Infarction

Atherosclerosis

Acute Coronary Syndrome

Others

By Location of testing:

Laboratory testing

Point of care testing

By Regions:

North America

o             U.S.

o             Canada

Europe

o             UK

o             Germany

o             ROE

Asia Pacific

o             China

o             India

o             Japan

o             ROAPEC

LAMEA

o             Brazil

o             Mexico

ROW

o             Middle East & Africa

Full Report Summary At: https://www.marketstudyreport.com/reports/global-cardiac-biomarkers-market-size-research?utm_source=marketwatch.com&utm_medium=TS

Related Report:

Global Advanced Metering Infrastructure Market Size study, by Device (Smart Meters) By Solution (Meter Data Management, Meter Data Analytics, Advanced Metering Infrastructure Security, Meter Communication Infrastructure) By Service (System Integration, Meter Deployment, Program Management and Consulting) and Regional Forecasts 2019-2026

Global Advanced Metering Infrastructure Market is valued approximately USD 6.8 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 15.50% over the forecast period 2019-2026. Advanced metering infrastructure (AMI) is an assimilated formation of communications networks, smart meters, and data management systems that allows two-way communication among customers and utilities.

https://www.marketstudyreport.com/reports/global-advanced-metering-infrastructure-market-size-research

About Us:

Market Study Report, LLC. is a hub for market intelligence products and services. We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place. Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: [email protected]

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

 

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close